Form 4 for AORT ARTIVION, INC.
Accepted 2023-02-15 00:00:00 ET · period of report 2023-02-13 · accession 0000784199-23-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-15 | 2023-02-13 | AORT | Davis John E | Senior VP, Gbl Sales | M - OptEx | $10.24 | +8,745 | 120.0K | +8% | +$89.5K |
| D | 2023-02-15 | 2023-02-13 | AORT | Davis John E | Senior VP, Gbl Sales | M - OptEx | $10.24 | -8,745 | 0 | -100% | -$89.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-13 | M | A | 8,745 | $10.24 | 120,017 | D | — | — | |
| 2 | Derivative | Stock Options (Right to buy) | 2023-02-13 | M | D | 8,745 | $10.24 | 0 | D | $10.24 · 2017-02-19 to 2023-02-19 | 8,745 Common Stock | (F1) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. |